Pediatric Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML) are both types of cancer that affect the blood and bone marrow. While ALL and AML share some similarities, they have some important differences as well.
Symptoms of Pediatric ALL and AML
Both ALL and AML can cause a wide variety of symptoms, including fatigue, fever, easy bruising, and frequent infections. Generally, AML may cause more severe symptoms than ALL. Additionally, people with ALL may experience swollen lymph nodes and an enlarged spleen, while those with AML may have an enlarged liver or spleen.
Diagnosis of Pediatric ALL and AML
To diagnose ALL and AML, doctors typically have to do a complete blood count and a bone marrow biopsy. In some cases, a doctor may also order a lumbar puncture and imaging tests such as X-rays or CT scans.
Treatment of Pediatric ALL and AML
The treatment for ALL and AML may vary depending on the severity of the cancer and the individual. Generally, ALL is treated with chemotherapy and radiation, while AML is treated with chemotherapy and sometimes a bone marrow transplant.
Outlook for Pediatric ALL and AML
The prognosis for ALL and AML is generally good, especially for those diagnosed at an early stage. The survival rate for ALL is generally higher than that of AML. However, it is important to note that the outlook can vary depending on the individual and the type and stage of cancer.